IBDEI0BM ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5485,1,4,0)
 ;;=4^CHRONIC SKIN ULCER NEC
 ;;^UTILITY(U,$J,358.3,5485,2)
 ;;=^271935
 ;;^UTILITY(U,$J,358.3,5486,0)
 ;;=707.9^^43^487^3
 ;;^UTILITY(U,$J,358.3,5486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5486,1,3,0)
 ;;=3^707.9
 ;;^UTILITY(U,$J,358.3,5486,1,4,0)
 ;;=4^CHRONIC SKIN ULCER NOS
 ;;^UTILITY(U,$J,358.3,5486,2)
 ;;=^24439
 ;;^UTILITY(U,$J,358.3,5487,0)
 ;;=731.8^^43^487^1
 ;;^UTILITY(U,$J,358.3,5487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5487,1,3,0)
 ;;=3^731.8
 ;;^UTILITY(U,$J,358.3,5487,1,4,0)
 ;;=4^BONE INVOLV IN OTH DIS
 ;;^UTILITY(U,$J,358.3,5487,2)
 ;;=^272681
 ;;^UTILITY(U,$J,358.3,5488,0)
 ;;=707.20^^43^487^8
 ;;^UTILITY(U,$J,358.3,5488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5488,1,3,0)
 ;;=3^707.20
 ;;^UTILITY(U,$J,358.3,5488,1,4,0)
 ;;=4^PRESSURE ULCER,STAGE UNSPEC
 ;;^UTILITY(U,$J,358.3,5488,2)
 ;;=^336761
 ;;^UTILITY(U,$J,358.3,5489,0)
 ;;=707.21^^43^487^4
 ;;^UTILITY(U,$J,358.3,5489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5489,1,3,0)
 ;;=3^707.21
 ;;^UTILITY(U,$J,358.3,5489,1,4,0)
 ;;=4^PRESSURE ULCER,STAGE I
 ;;^UTILITY(U,$J,358.3,5489,2)
 ;;=^336649
 ;;^UTILITY(U,$J,358.3,5490,0)
 ;;=707.22^^43^487^5
 ;;^UTILITY(U,$J,358.3,5490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5490,1,3,0)
 ;;=3^707.22
 ;;^UTILITY(U,$J,358.3,5490,1,4,0)
 ;;=4^PRESSURE ULCER,STAGE II
 ;;^UTILITY(U,$J,358.3,5490,2)
 ;;=^336650
 ;;^UTILITY(U,$J,358.3,5491,0)
 ;;=707.23^^43^487^6
 ;;^UTILITY(U,$J,358.3,5491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5491,1,3,0)
 ;;=3^707.23
 ;;^UTILITY(U,$J,358.3,5491,1,4,0)
 ;;=4^PRESSURE ULCER,STAGE III
 ;;^UTILITY(U,$J,358.3,5491,2)
 ;;=^336651
 ;;^UTILITY(U,$J,358.3,5492,0)
 ;;=707.24^^43^487^7
 ;;^UTILITY(U,$J,358.3,5492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5492,1,3,0)
 ;;=3^707.24
 ;;^UTILITY(U,$J,358.3,5492,1,4,0)
 ;;=4^PRESSURE ULCER,STAGE IV
 ;;^UTILITY(U,$J,358.3,5492,2)
 ;;=^336652
 ;;^UTILITY(U,$J,358.3,5493,0)
 ;;=V18.0^^43^488^1
 ;;^UTILITY(U,$J,358.3,5493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5493,1,3,0)
 ;;=3^V18.0
 ;;^UTILITY(U,$J,358.3,5493,1,4,0)
 ;;=4^FAM HX-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,5493,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,5494,0)
 ;;=V58.67^^43^488^2
 ;;^UTILITY(U,$J,358.3,5494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5494,1,3,0)
 ;;=3^V58.67
 ;;^UTILITY(U,$J,358.3,5494,1,4,0)
 ;;=4^LONG-TERM USE OF INSULIN
 ;;^UTILITY(U,$J,358.3,5494,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,5495,0)
 ;;=V68.1^^43^488^3
 ;;^UTILITY(U,$J,358.3,5495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5495,1,3,0)
 ;;=3^V68.1
 ;;^UTILITY(U,$J,358.3,5495,1,4,0)
 ;;=4^ISSUE REPEAT PRESCRIPT
 ;;^UTILITY(U,$J,358.3,5495,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,5496,0)
 ;;=V67.59^^43^488^4
 ;;^UTILITY(U,$J,358.3,5496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5496,1,3,0)
 ;;=3^V67.59
 ;;^UTILITY(U,$J,358.3,5496,1,4,0)
 ;;=4^FOLLOW-UP EXAM NEC
 ;;^UTILITY(U,$J,358.3,5496,2)
 ;;=^295581
 ;;^UTILITY(U,$J,358.3,5497,0)
 ;;=249.00^^43^489^17
 ;;^UTILITY(U,$J,358.3,5497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5497,1,3,0)
 ;;=3^249.00
 ;;^UTILITY(U,$J,358.3,5497,1,4,0)
 ;;=4^SEC DM W/O COMP NOT UNCNTRLD
 ;;^UTILITY(U,$J,358.3,5497,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,5498,0)
 ;;=249.01^^43^489^18
 ;;^UTILITY(U,$J,358.3,5498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5498,1,3,0)
 ;;=3^249.01
 ;;^UTILITY(U,$J,358.3,5498,1,4,0)
 ;;=4^SEC DM WO COMP UNCONTRLD
 ;;^UTILITY(U,$J,358.3,5498,2)
 ;;=^336527
 ;;^UTILITY(U,$J,358.3,5499,0)
 ;;=249.10^^43^489^5
 ;;^UTILITY(U,$J,358.3,5499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5499,1,3,0)
 ;;=3^249.10
